Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 7:39 p.m.

    📋 enGene Inc (ENGNW) - Clinical Trial Update

    Filing Date: 2026-01-21

    Accepted: 2026-01-21 07:38:06

    Event Type: Clinical Trial Update

    Event Details:

    enGene Inc (ENGNW) Announces Clinical Trial Update enGene Inc (ENGNW) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: treatment, carcinoma
    • Diseases/Conditions: high-risk
    • Collaboration: facilityBOSTON & MONTREAL

    🔬 Clinical Development Pipeline (enGene Inc):

    Product Type Development Stage Therapeutic Area Source
    Treatment 5 DRUG Phase PHASE1 Prevention of Herpes Zoster (HZ) ClinicalTrials.gov
    EG-70 (phase 2) DRUG Phase PHASE1 Superficial Bladder Cancer ClinicalTrials.gov
    EG-70 (phase 1) DRUG Phase PHASE1 Superficial Bladder Cancer ClinicalTrials.gov
    The DyaMX Device DEVICE Approved Type 2 Diabetes ClinicalTrials.gov
    The Endogenex Device DEVICE Approved Diabetes ClinicalTrials.gov
    Menveo BIOLOGICAL Phase PHASE2 Meningococcal Infections ClinicalTrials.gov
    EG-MCV4 BIOLOGICAL Phase PHASE2 Meningococcal Infections ClinicalTrials.gov
    Endogenex System DEVICE Approved Type 2 Diabetes Mellitus ClinicalTrials.gov
    Treatment 4 (EG-HZ-004) DRUG Phase PHASE1 Prevention of Herpes Zoster (HZ) ClinicalTrials.gov
    Treatment 3 (EG-HZ-003) DRUG Phase PHASE1 Prevention of Herpes Zoster (HZ) ClinicalTrials.gov
    Treatment 2 (EG-HZ-002) DRUG Phase PHASE1 Prevention of Herpes Zoster (HZ) ClinicalTrials.gov
    Treatment 1 (EG-HZ-001) DRUG Phase PHASE1 Prevention of Herpes Zoster (HZ) ClinicalTrials.gov
    Juvene IOL DEVICE Approved Cataract ClinicalTrials.gov
    Tecnis® Monofocal (ZCB00, PCB00 or DCB00) DEVICE Approved Cataract ClinicalTrials.gov
    ET-01 BIOLOGICAL Approved Transfusion Dependent Beta-Thalassaemia ClinicalTrials.gov
    Cyclophosphamide DRUG Phase PHASE1 Lupus Erythematosus, Systemic ClinicalTrials.gov
    Fludarabine DRUG Phase PHASE1 Lupus Erythematosus, Systemic ClinicalTrials.gov
    ATHENA CAR-T BIOLOGICAL Phase PHASE1 Lupus Erythematosus, Systemic ClinicalTrials.gov
    Sham Procedure DEVICE Approved Type 2 Diabetes Mellitus ClinicalTrials.gov
    ReCET Treatment DEVICE Approved Type 2 Diabetes Mellitus ClinicalTrials.gov
    TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T) BIOLOGICAL Phase PHASE1 Non Hodgkin's Lymphoma ClinicalTrials.gov
    EG-COVII BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    C: EG-COVARo DRUG Phase PHASE1 COVID-19 Vaccine ClinicalTrials.gov
    B: EG-COVID DRUG Phase PHASE1 COVID-19 Vaccine ClinicalTrials.gov
    A: EG-COVID DRUG Phase PHASE1 COVID-19 Vaccine ClinicalTrials.gov
    EG-COVID-001 DRUG Phase PHASE1 COVID-19 Vaccine ClinicalTrials.gov
    EG-COVID-003 DRUG Phase PHASE1 COVID-19 Vaccine ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: enGene Inc
    • Ticker Symbol: ENGNW

Search

News categories